Metasphere Labs Inc.
LABZ
CNSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -109.19% | -- | -96.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -109.19% | -- | -96.72% |
| Cost of Revenue | -- | -- | -154.12% | -- | -78.99% |
| Gross Profit | -- | -- | -100.60% | -- | -99.78% |
| SG&A Expenses | -15.31% | -59.71% | -52.94% | -36.33% | 11.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -29.91% | -62.85% | -63.16% | -55.85% | -37.92% |
| Operating Income | 14.37% | 62.85% | 26.91% | -272.17% | -121.04% |
| Income Before Tax | 14.32% | 62.73% | 72.55% | -201.46% | -121.32% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 14.32% | 62.73% | 72.55% | -201.46% | -121.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 14.32% | 62.73% | 72.55% | -201.46% | -121.32% |
| EBIT | 14.37% | 62.85% | 26.91% | -272.17% | -121.04% |
| EBITDA | -- | -- | 27.49% | -229.71% | -119.48% |
| EPS Basic | 18.42% | 67.80% | 80.06% | -202.68% | -108.65% |
| Normalized Basic EPS | 18.75% | 68.24% | 54.79% | -292.00% | -111.01% |
| EPS Diluted | 18.42% | 67.80% | 80.06% | -365.09% | -112.82% |
| Normalized Diluted EPS | 18.75% | 68.24% | 54.79% | -374.29% | -119.35% |
| Average Basic Shares Outstanding | 5.86% | 16.05% | 37.40% | -0.83% | 145.97% |
| Average Diluted Shares Outstanding | 5.86% | 16.05% | 37.40% | -29.42% | 39.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |